Report ID: SQSG35H2019
Biopharmaceuticals Contract Manufacturing Market Size, Share, Growth Analysis, By Source(Mammalian, Non-mammalian), By Service(Process Development, Fill & Finish Operations, Packaging, others), By Product Type(Interferon, Monoclonal Antibodies, Protein, Vaccines), By Therapeutic Applications(Oncology, Cardiovascular Diseases, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35H2019 |
Region:
Global |
Published Date: April, 2024
Pages:
157
|
Tables:
120 |
Figures:
77
Biopharmaceuticals Contract Manufacturing Market Regional Insights
Globally, North America region dominated the biopharmaceuticals contract manufacturing with a holding of strong market share in 2021 due to the large number of biomanufacturing facilities in the United States. Additionally, interventions & conferences conducted in the North America for pertinent developing technologies and major issues in applications of biologics for the better treatment of several chronic disorders are likely to fuel the adoption of contract manufacturing services in the region over the coming years.
Furthermore, Asia Pacific is expected to grow at fastest CAGR during the forecast period owing to emergence of the regional market as an attractive outsourcing market for the biomanufacturing of large molecules. In addition, low manufacturing cost and cheap labour cost offered by developing countries like India and China, is also projected to drive the growth and demand of the market in the region. Increasing number of manufacturing facilities opening by international players in the region due to availability of high growth opportunities in the region, is also propelling the market growth and expansion during the forecast period.
Biopharmaceuticals Contract Manufacturing Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
